Google and CTC Global Announce Initiative to Expand American Electric Grid and Transmission Capacity, U.S. Supply Chain with Advanced Conductors
Today, Google announced a collaboration with CTC Global Corporation (CTC Global) to accelerate the deployment of next-generation transmission technology for the U.S. power grid. Together, Google and CTC Global will help scale the use of CTC Global’s high-capacity, U.S.-manufactured advanced conductors, a proven technology demonstrated to boost grid capacity and reliability at unparalleled speed.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617507388/en/
ACCC® Conductor Installation
Google and CTC Global will identify high-impact transmission lines through a Request for Information (RFI) to states, utilities, and transmission developers interested in collaborating on solutions to unlock grid capacity across the country. Deployment of advanced conductors like CTC Global’s has the potential to double transmission capacity in months, as opposed to the years typically needed for new transmission builds (and in some cases as much as 10 years).
Rapid access to reliable, safe, and efficient transmission infrastructure is fundamental to enabling America's energy future. This initiative is designed to accelerate regional economic growth and development, add capacity, improve grid reliability and performance, and lower energy costs for all.
A New Customer Approach to Accelerate Transmission Infrastructure
As a part of this collaboration, transmission lines across the U.S. will be selected based on their potential to accelerate grid capacity with CTC Global’s ACCC® Conductor. The initiative will prioritize projects that can deliver the greatest immediate impact and that support load growth where Google operates.
To identify transmission line projects for this initiative, states, utilities, and transmission developers can respond to the RFI issued today. Selected partners and projects will gain access to a powerful combination of Google and CTC Global resources designed to accelerate deployment, including:
- Cost Assistance: Funding will be available to accelerate deployment of CTC Global’s high-capacity ACCC® Conductors and accelerate capacity growth.
- Future-Ready Workforce Development: Utilities will be eligible for training to equip their workforce in the deployment of ACCC Advanced Conductors.
- Technical Analysis: Support for technical project studies will be available to validate the technology's integration and impact.
RFI responses are due on July 14, 2025, with a full RFP to shortly follow. Applications are encouraged from areas where Google has existing or announced data centers, as well as their associated wholesale markets.
“Expanding transmission capacity presents a significant opportunity for the power system today, and Google is committed to being a catalyst for a stronger and more reliable U.S. power grid. Expanded grid capacity will enable responsible data center growth underpinning the modern digital world, while also increasing affordability for consumers, boosting energy reliability, and accelerating key industries like manufacturing,” said Amanda Peterson Corio, Google Global Head of Data Center Energy. “Working with CTC Global, this partnership aims to dramatically cut the time and cost of adding and moving electricity to reliably power American homes and businesses.”
“This groundbreaking partnership with Google marks a positive turning point to lower electricity costs, generate economic growth, and advance U.S. energy dominance,” stated CTC Global CEO J.D. Sitton. “Our solution uniquely delivers significant electric grid capacity with unparalleled speed. This coordinated partnership with the innovators at Google will help ensure that the U.S. invests in cost-effective solutions for the long-term that help the U.S. continue to lead the AI revolution,” Sitton explained.
Supporting U.S. Manufacturing Capabilities
CTC Global proudly manufactures and assembles its advanced conductor technologies in the United States, supplying the ACCC Conductor to projects in more than 30 U.S. states. CTC is also a major manufacturing exporter, with ACCC Advanced Conductor projects now installed in over 65 countries. Utilizing U.S. suppliers of carbon fiber from Arkansas, fiberglass from Texas, and other key U.S. components, CTC has been powering U.S. job creation at its U.S. factory in Irvine, California, for over 20 years. Partnering with Google to accelerate deployment of carbon-composite conductors will deliver urgently needed transmission capacity while continuing to expand this made-in-America capability and support America's competitive edge globally.
Inquiries regarding the RFI and RFI eligibility may be directed to Google and CTC Global at ctc-external@google.com.
About Google:
Google's mission is to organize the world's information and make it universally accessible and useful. Through products and platforms like Search, Maps, Gmail, Android, Google Play, Google Cloud, Chrome and YouTube, Google plays a meaningful role in the daily lives of billions of people and has become one of the most widely-known companies in the world. Google is a subsidiary of Alphabet Inc.
About CTC Global:
CTC Global is accelerating access to energy as the world’s leading developer and manufacturer of high-capacity advanced conductors. With over 124,000 miles deployed over the last two decades, CTC Global’s ACCC® Advanced Conductor is the most aggressively tested and widely installed advanced conductor in North America and the world, used by over 300 utility and industrial customers in over 65 countries and 30 U.S. states to rapidly deliver the greatest amount of electricity at the lowest capital cost. The high strength, light weight, improved conductivity, and thermal stability of ACCC® can allow it to double the capacity of existing transmission lines without the need to raise or replace existing structures. The ACCC® Conductor mitigates thermal sag to help mitigate wildfire and extreme weather risks, lower overall project costs, reduces line losses by up to 40%, and cut project lead times from years to months. Headquartered in Irvine, California, over half of CTC Global’s manufacturing capacity is U.S. based. For over 20 years, CTC Global has been a pioneer in the energy space, developing and manufacturing the most responsible and innovative solution to double capacity and improve reliability at scale. For more information, visit www.ctcglobal.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250617507388/en/
Contacts
CTC Global
Tyler Dalton
+1 (949) 428-8500
tdalton@ctcglobal.com
DGA Group
+1 212 466 6450 x 0
ctc@dgagroup.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press Release
Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeking future-ready solutions. At the core of this strategy is Regnology Risk Hub (RRiskHub), an integrated solution designed to deliver a single
Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press Release
Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press Release
Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at week 16, with a significantly greater PASI 75 response rate seen as early as week 4 and continuing to increase through week 24. The studies also met all 44 ranked secondary endpoints, including PASI 90, PASI 100 and sPGA 0 against placebo and apremilast, showing the potential of a convenient once-daily pill to deliver complete skin clearance for patients with PsO. “People living with psoriasis continue to seek safe, effective and fast-acting oral therap
DATROWAY ® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press Release
The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Products for Human Use. The application is based on data from the TROPION-Breast02 phase 3 trial presented in a late-breaking proffered paper session at the 2025 European Society for Medical Oncology (#ESMO25) Congress. In the trial, DATROWAY demonstrated statistically significant and clinical
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press Release
Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution for intravenous infusion. “The new SteQeyma™ autoinjector brings together convenience and practical usability to meet the everyday challenges faced by patients living with chronic inflammatory diseases. The full range of our SteQeyma™ dosage forms and strengths, with the autoinjector now added, provides patients and healthcare professionals with more individualized treatm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom